# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T18:56:44.811021
**Response ID:** resp_0c20a823f4a808c800697b9eb4854c8196a1d40c20e2c1ccef
**Tokens:** 19365 in / 6163 out
**Response SHA256:** d165744a950a9fc1

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

- **Treatment timing vs. data coverage:** Your main outcome series (BFS application-based series) are stated to cover **2005–2024**, and your latest treatment cohort is **2024 (OH)**. This satisfies the required condition **max(treatment year) ≤ max(data year)** for the main DiD analyses.
- **Post-treatment observations by cohort:** Every cohort through 2023 has at least one post-treatment year; the **2024 cohort has exactly one** (2024). That is limited but not a data-design impossibility.
- **Treatment definition consistency:** Throughout the paper you define treatment as **first legal recreational retail sales**, and Table 1 is consistent with that definition. Regressions use “Rec. Retail Sales” as the treatment indicator aligned to that timing.

**No fatal data–design misalignment found.**

---

## 2) REGRESSION SANITY (CRITICAL)

I checked the reported tables for “obviously broken” outputs:

- **Table 3 (TWFE):** Coefficients and SEs are in plausible ranges for log per-capita outcomes (e.g., −0.068 with SE 0.040). R² values are within [0,1].
- **Table 4 (Callaway–Sant’Anna):** ATT magnitudes and SEs are plausible; no impossible values.
- **Table 5 (TWFE across BFS series):** Coefficients/SEs plausible; no extreme or nonsensical values; R² within [0,1].
- **Table 6 (robustness summary):** No impossible entries (no NA/NaN/Inf), and p-values are valid.

**No fatal regression-sanity violations found (per the criteria you specified).**

---

## 3) COMPLETENESS (CRITICAL)

- No visible placeholders (“TBD”, “XXX”, “NA/NaN/Inf” in tables).
- Regression tables report **standard errors and sample sizes (N)**.
- The analyses described in the text (TWFE, CS, event study, randomization inference, pairs cluster bootstrap, medical-only controls, excluding COVID years) are **all reported somewhere** in the draft excerpt (tables/figures/appendix descriptions).

**No fatal completeness issues found.**

---

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Key numeric claims in text match the corresponding tables (e.g., TWFE ≈ −0.068; CS overall ATT ≈ −0.028; RI p = 0.093; bootstrap p = 0.064).
- Sample periods are consistently described: application outcomes use **2005–2024**; BF8Q uses **2005–2020** and you explicitly flag the BF8Q timing problem as non-causal.
- Table/figure references shown in the excerpt appear to exist and align with descriptions.

**No fatal internal-consistency contradictions found.**

---

ADVISOR VERDICT: PASS